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Purpose
Childhood onset Lupus (cSLE) is a chronic condition
that usually requires life-long care, and optimizing self-
management skills for youth with cSLE may improve
health outcomes. This project aims to evaluate the
impact of an educational intervention with a pediatric
SLE-specific health passport (pLHP) for transitioning
youth with cSLE.
Methods
We adapted the pHLP from an adult LHP developed by
the Canadian Network for Improved Outcomes in SLE
(CaNIOS), by modifying the content and design to tailor
to the needs of teens; and we then assessed acceptability
through pilot testing and structured interviews. Patients
with cSLE age 14-21 years recruited from three North
American centers were instructed on the use of the
pLHP. Transition readiness was assessed by a modified
version of the California Healthy and Ready to Work
Transition Health Care Guide, self-efficacy by a modi-
fied version of the Children’s Arthritis Self-Efficacy
Scale, medication adherence by the MASRI, and SLE
knowledge by a tool developed by the investigators.
Baseline data is presented here.
Results
48 patients aged 14.4 -21.2 yrs (mean 17.8 yrs), 79%
female, with mean age of diagnosis of 13 yrs (range 7 -17
yrs) and mean disease duration of 5 years (range 0.4-12
yrs) were evaluated. Current medications included pla-
quenil (85%), mycophenolate (59%), rituximab (11%),
azathioprine (7%), methotrexate (7%), anti-depressant
(14%) and history of cyclophosphamide (29%). Median
disease activity at enrollment by SLEDAI was 0 (range 0-
14); median cumulative damage by SLICC/Damage Index
was 0 (range 0-2). On an SLE knowledge test of 12 true/
false questions the median score was 80% correct (range
5-100%) and on a 10 question fill-in-the-blank knowledge
test, the median score was 60% (range 10-90%). Age was
associated with higher knowledge on the true/false test
(r=0.6, p=0.0025). Self-efficacy scores varied widely
(mean 54, range 38-65). Transition readiness (assessed
with a 3-point likert scale; 1= I am doing this, 2=I need
some help, 3=someone else does this for me) revealed a
mean score across all tasks of 1.5 suggesting that many
patients were dependent on others to complete health
care tasks. Overall transition readiness was associated
with increased age (r=0.6, p=0.001). Self-reported adher-
ence for taking prednisone was good: 35% indicated tak-
ing all medication doses, 23% indicated taking 90% of
doses, 10 % indicated taking 85%, and none reported less
than 60% adherence. To date, 6 patients have undergone
a 6 month follow-up visit and our preliminary impression
is that although most patients agree that the pLHP is
informative, many are not routinely entering their perso-
nal disease-related information.
Conclusion
Teens with SLE have variable self-efficacy and are in need
of education about their disease and their medications.
Many teens with cSLE still rely on their parents for assis-
tance with medical tasks. We are continuing our follow-up
visits and anticipate that the pLHP will significantly bridge
gaps in knowledge and self-efficacy and positively impact
future self care and health outcomes.
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